Elevidys™ (delandistrogene moxeparvovec-rokl)
| Full Name | Elevidys™ (delandistrogene moxeparvovec-rokl) |
| Drug | Elevidys |
| Manufacturer | Sarepta Therapeutics, Inc. |
| Route of Administration | Intravenous |
| Site of Care | Healthcare Facility |
| Approved Indication | Treatment of Duchenne muscular dystrophy (DMD) in individuals at least 4 years of age:
|
| Disease | Duchenne muscular dystrophy (DMD) |
| Therapeutic Area | Neurology; Genetics; Cell & Gene Therapy |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-870-8931 |
| Fax Number | 877-694-2546 |
| Product Website | elevidyshcp.com |
| Patient Resources | Alex Rezcalla Foundation, Jett Foundation, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy |